Information Journal Paper
APA:
Copy. (2019). Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells. BIOMEDICINE & PHARMACOTHERAPY, 109(-), 0-0. SID. https://sid.ir/paper/1044479/en
Vancouver:
Copy. Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells. BIOMEDICINE & PHARMACOTHERAPY[Internet]. 2019;109(-):0-0. Available from: https://sid.ir/paper/1044479/en
IEEE:
Copy, “Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells,” BIOMEDICINE & PHARMACOTHERAPY, vol. 109, no. -, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/1044479/en